Insight

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei and Katy Rezvani

Dec 9, 2024, 13:23

Hind Rafei: Brief Updates on CAR-Natural Killer Cell Therapy for Cancer

Hind Rafei, Assistant Professor in the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center, shared a recent article on X:

“Please check out our recent in a Nutshell article for brief updates on CAR-Natural killer cell therapy for cancer.

Lots of new exciting frontiers in the field.”

Title: Advances and challenges in chimeric antigen receptor-natural killer cell immunotherapy for cancer

Authors: Hind Rafei and Katayoun Rezvani

More posts featuring Hind Rafei.

antigen receptor British Journal of Haematology cancer Hind Rafei immunotherapy Journal of Haematology Katayoun Rezvani MD Anderson Cancer Center Natural Killer cell OncoDaily Oncology Stem Cell Transplantation therapy

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity